共 6 条
- [1] In patients hospitalized for COVID-19, does baricitinib reduce 28-days mortality compared to standard treatment, and is it safe? REVUE DE MEDECINE INTERNE, 2022, 43 (10): : 634 - 635
- [2] SEVERE COMMUNITY ACQUIRED PNEUMONIA - A STUDY OF CONSECUTIVE ADULTS ADMITTED TO AN INTENSIVE-CARE UNIT EUROPEAN JOURNAL OF RESPIRATORY DISEASES, 1983, 64 : 592 - 592
- [3] In patients hospitalized for COVID-19, does dexamethasone reduce 28-days mortality compared to standard treatment? REVUE DE MEDECINE INTERNE, 2020, 41 (11): : 790 - 791
- [4] In patients hospitalized for COVID-19 with hypoxia and systemic inflammation, does tocilizumab reduce 28-days mortality compared to standard treatment, and is it safe? REVUE DE MEDECINE INTERNE, 2021, 42 (07): : 517 - 518
- [5] Clinical picture and prognostic factors for severe community-acquired pneumonia in adults admitted to the intensive care unit ARCHIVOS DE BRONCONEUMOLOGIA, 2005, 41 (01): : 20 - 26